{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T19:15:29Z","timestamp":1790795729859,"version":"4.1.0"},"reference-count":242,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,11,2]],"date-time":"2019-11-02T00:00:00Z","timestamp":1572652800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008069","name":"University of California, San Francisco","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DK26506"],"award-info":[{"award-number":["DK26506"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["GM44037"],"award-info":[{"award-number":["GM44037"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK26743"],"award-info":[{"award-number":["DK26743"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Pharmaceutica Sinica B"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.apsb.2019.11.002","type":"journal-article","created":{"date-parts":[[2019,11,8]],"date-time":"2019-11-08T13:01:56Z","timestamp":1573218116000},"page":"42-60","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Cytochrome P450 endoplasmic reticulum-associated degradation (ERAD): therapeutic and pathophysiological implications"],"prefix":"10.1016","volume":"10","author":[{"given":"Doyoung","family":"Kwon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Mi","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Almira","family":"Correia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apsb.2019.11.002_bib1","series-title":"Cytochrome P450: structure, mechanism and biochemistry","first-page":"523","article-title":"Human cytochrome P450 enzymes","author":"Guengerich","year":"2015"},{"key":"10.1016\/j.apsb.2019.11.002_bib2","series-title":"Basic and clinical pharmacology","first-page":"56","article-title":"Drug biotransformation","author":"Correia","year":"2018"},{"key":"10.1016\/j.apsb.2019.11.002_bib3","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0031-6997(25)00021-3","article-title":"The molecular biology of cytochrome P450s","volume":"40","author":"Gonzalez","year":"1988","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.apsb.2019.11.002_bib4","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/00008571-199302000-00006","article-title":"Regulation of cytochrome P450 genes: molecular mechanisms","volume":"3","author":"Gonzalez","year":"1993","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.apsb.2019.11.002_bib5","series-title":"Cytochrome P450: structure, mechanism and biochemistry","first-page":"787","article-title":"Nuclear receptor-mediated regulation of cytochrome P450 genes","author":"Gotoh","year":"2015"},{"key":"10.1016\/j.apsb.2019.11.002_bib6","doi-asserted-by":"crossref","first-page":"6264","DOI":"10.1016\/S0021-9258(19)84558-1","article-title":"Macrolide antibiotics inhibit the degradation of the glucocorticoid-responsive cytochrome P-450p in rat hepatocytes in\u00a0vivo and in primary monolayer culture","volume":"261","author":"Watkins","year":"1986","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2019.11.002_bib7","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1016\/S0021-9258(18)94103-7","article-title":"Induction of rat hepatic N-nitrosodimethylamine demethylase by acetone is due to protein stabilization","volume":"264","author":"Song","year":"1989","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2019.11.002_bib8","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1006\/bbrc.1994.2774","article-title":"Induction of CYP2E1 in liver, kidney, brain and intestine during chronic ethanol administration and withdrawal: evidence that CYP2E1 possesses a rapid phase half-life of 6 hours or less","volume":"205","author":"Roberts","year":"1994","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.apsb.2019.11.002_bib9","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/0003-9861(92)90666-K","article-title":"Degradation of rat liver cytochromes P450 3A after their inactivation by 3,5-dicarbethoxy-2,6-dimethyl-4-ethyl-1,4-dihydropyridine: characterization of the proteolytic system","volume":"297","author":"Correia","year":"1992","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.apsb.2019.11.002_bib10","first-page":"1228","article-title":"Mechanisms of enhanced oral availability of CYP3A4 substrates by grapefruit constituents. Decreased enterocyte CYP3A4 concentration and mechanism-based inactivation by furanocoumarins","volume":"25","author":"Schmiedlin-Ren","year":"1997","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.apsb.2019.11.002_bib11","doi-asserted-by":"crossref","first-page":"a013185","DOI":"10.1101\/cshperspect.a013185","article-title":"The mammalian endoplasmic reticulum-associated degradation system","volume":"5","author":"Olzmann","year":"2013","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.apsb.2019.11.002_bib12","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nsmb.2793","article-title":"Cleaning up in the endoplasmic reticulum: ubiquitin in charge","volume":"21","author":"Christianson","year":"2014","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.apsb.2019.11.002_bib13","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1042\/BCJ20160582","article-title":"The evolving role of ubiquitin modification in endoplasmic reticulum-associated degradation","volume":"474","author":"Preston","year":"2017","journal-title":"Biochem J"},{"key":"10.1016\/j.apsb.2019.11.002_bib14","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0076-6879(91)06101-8","article-title":"Cytochrome P450 turnover","volume":"206","author":"Correia","year":"1991","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.apsb.2019.11.002_bib15","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1081\/DMR-120023683","article-title":"Hepatic cytochrome P450 degradation: mechanistic diversity of the cellular sanitation brigade","volume":"35","author":"Correia","year":"2003","journal-title":"Drug Metab Rev"},{"key":"10.1016\/j.apsb.2019.11.002_bib16","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1146\/annurev.pharmtox.45.120403.100127","article-title":"Cytochrome P450 ubiquitination: branding for the proteolytic slaughter?.","volume":"45","author":"Correia","year":"2005","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.apsb.2019.11.002_bib17","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1080\/03602532.2016.1195403","article-title":"Hepatic cytochromes P450: structural degrons and barcodes, posttranslational modifications and cellular adapters in the ERAD-endgame","volume":"48","author":"Kim","year":"2016","journal-title":"Drug Metab Rev"},{"key":"10.1016\/j.apsb.2019.11.002_bib18","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1006\/abbi.1999.1139","article-title":"Cytochrome P450 3A degradation in isolated rat hepatocytes: 26S proteasome inhibitors as probes","volume":"365","author":"Wang","year":"1999","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.apsb.2019.11.002_bib19","doi-asserted-by":"crossref","first-page":"7793","DOI":"10.1021\/bi700340n","article-title":"Characterization of the physiological turnover of native and inactivated cytochromes P450 3A in cultured rat hepatocytes: a role for the cytosolic AAA ATPase p97?.","volume":"46","author":"Faouzi","year":"2007","journal-title":"Biochemistry"},{"key":"10.1016\/j.apsb.2019.11.002_bib20","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/0006-291X(91)91391-O","article-title":"Post-translational reduction of cytochrome P450IIE by CCl4, its substrate","volume":"179","author":"Sohn","year":"1991","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.apsb.2019.11.002_bib21","doi-asserted-by":"crossref","first-page":"9771","DOI":"10.1074\/jbc.272.15.9771","article-title":"Evidence of proteasome-mediated cytochrome P-450 degradation","volume":"272","author":"Roberts","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2019.11.002_bib22","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0003-9861(92)90358-4","article-title":"Degradation of cytochrome P450 2E1: selective loss after labilization of the enzyme","volume":"293","author":"Tierney","year":"1992","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.apsb.2019.11.002_bib23","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1074\/jbc.M708821200","article-title":"Nitric oxide-dependent proteasomal degradation of cytochrome P450 2B proteins","volume":"283","author":"Lee","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2019.11.002_bib24","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.freeradbiomed.2017.04.015","article-title":"Nitric oxide-regulated proteolysis of human CYP2B6 via the ubiquitin-proteasome system","volume":"108","author":"Lee","year":"2017","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.apsb.2019.11.002_bib25","series-title":"Cytochrome P450: structure, mechanism and biochemistry","first-page":"183","article-title":"Structures of eukaryotic cytochromes P450 enzymes","author":"Von Wachenfeldt","year":"1995"},{"key":"10.1016\/j.apsb.2019.11.002_bib26","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1006\/abbi.1996.9859","article-title":"Microsomal P450 2C3 is expressed as a soluble dimer in Escherichia coli following modification of its N-terminus","volume":"339","author":"von Wachenfeldt","year":"1997","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.apsb.2019.11.002_bib27","doi-asserted-by":"crossref","first-page":"15790","DOI":"10.1073\/pnas.1521919112","article-title":"mTOR inhibition activates overall protein degradation by the ubiquitin proteasome system as well as by autophagy","volume":"112","author":"Zhao","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.apsb.2019.11.002_bib28","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.tcb.2004.07.013","article-title":"Checkpoints in ER-associated degradation: excuse me, which way to the proteasome?.","volume":"14","author":"Ahner","year":"2004","journal-title":"Trends Cell Biol"},{"key":"10.1016\/j.apsb.2019.11.002_bib29","doi-asserted-by":"crossref","first-page":"35903","DOI":"10.1074\/jbc.M301080200","article-title":"Use of modular substrates demonstrates mechanistic diversity and reveals differences in chaperone requirement of ERAD","volume":"278","author":"Taxis","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2019.11.002_bib30","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1083\/jcb.200309132","article-title":"Misfolded proteins are sorted by a sequential checkpoint mechanism of ER quality control","volume":"165","author":"Vashist","year":"2004","journal-title":"J Cell Biol"},{"key":"10.1016\/j.apsb.2019.11.002_bib31","first-page":"657","article-title":"CYP2E1\u2014biochemical and toxicological aspects and role in alcohol-induced liver injury","volume":"73","author":"Cederbaum","year":"2006","journal-title":"Mt Sinai J Med"},{"key":"10.1016\/j.apsb.2019.11.002_bib32","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.yexmp.2006.07.007","article-title":"CYP2E1 induced by ethanol causes oxidative stress, proteasome inhibition and cytokeratin aggresome (Mallory body-like) formation","volume":"81","author":"Bardag-Gorce","year":"2006","journal-title":"Exp Mol Pathol"},{"key":"10.1016\/j.apsb.2019.11.002_bib33","doi-asserted-by":"crossref","first-page":"33698","DOI":"10.1074\/jbc.M805999200","article-title":"Structures of human cytochrome P-450 2E1. Insights into the binding of inhibitors and both small molecular weight and fatty acid substrates","volume":"283","author":"Porubsky","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2019.11.002_bib34","doi-asserted-by":"crossref","first-page":"18378","DOI":"10.1016\/S0021-9258(17)32318-9","article-title":"Substrate-regulated, cAMP-dependent phosphorylation, denaturation, and degradation of glucocorticoid-inducible rat liver cytochrome P450 3A1","volume":"269","author":"Eliasson","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2019.11.002_bib35","series-title":"Enzyme inhibition in drug discovery & development","first-page":"363","article-title":"Cytochrome P450 degradation and its clinical relevance","author":"Liao","year":"2010"},{"key":"10.1016\/j.apsb.2019.11.002_bib36","doi-asserted-by":"crossref","first-page":"25895","DOI":"10.1074\/jbc.M303125200","article-title":"Liver-specific deletion of the NADPH-cytochrome P450 reductase gene: impact on plasma cholesterol homeostasis and the function and regulation of microsomal cytochrome P450 and heme oxygenase","volume":"278","author":"Gu","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2019.11.002_bib37","doi-asserted-by":"crossref","first-page":"13480","DOI":"10.1074\/jbc.M212087200","article-title":"Inactivation of the hepatic cytochrome P450 system by conditional deletion of hepatic cytochrome P450 reductase","volume":"278","author":"Henderson","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2019.11.002_bib38","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1006\/abbi.1999.1399","article-title":"NADPH-dependent microsomal electron transfer increases degradation of CYP2E1 by the proteasome complex: role of reactive oxygen species","volume":"370","author":"Goasduff","year":"1999","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.apsb.2019.11.002_bib39","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1042\/bj3400453","article-title":"Relationship between cytochrome P450 catalytic cycling and stability: fast degradation of ethanol-inducible cytochrome P450 2E1 (CYP2E1) in hepatoma cells is abolished by inactivation of its electron donor NADPH-cytochrome P450 reductase","volume":"340","author":"Zhukov","year":"1999","journal-title":"Biochem J"},{"key":"10.1016\/j.apsb.2019.11.002_bib40","doi-asserted-by":"crossref","first-page":"15765","DOI":"10.1016\/S0021-9258(19)49601-4","article-title":"Hormone- and substrate-regulated intracellular degradation of cytochrome P450\u00a0(2E1) involving MgATP-activated rapid proteolysis in the\u00a0endoplasmic reticulum membranes","volume":"267","author":"Eliasson","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2019.11.002_bib41","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1006\/abbi.1999.1138","article-title":"Proteolytic degradation of heme-modified hepatic cytochromes P450: a role for phosphorylation, ubiquitination, and the 26S proteasome?.","volume":"365","author":"Korsmeyer","year":"1999","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.apsb.2019.11.002_bib42","doi-asserted-by":"crossref","first-page":"11318","DOI":"10.1021\/bi010690z","article-title":"Phosphorylation of native and heme-modified CYP3A4 by protein kinase C: a mass spectrometric characterization of the phosphorylated peptides","volume":"40","author":"Wang","year":"2001","journal-title":"Biochemistry"},{"key":"10.1016\/j.apsb.2019.11.002_bib43","doi-asserted-by":"crossref","first-page":"5671","DOI":"10.1074\/jbc.M806104200","article-title":"A role for protein phosphorylation in cytochrome P450 3A4 ubiquitin-dependent proteasomal degradation","volume":"284","author":"Wang","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2019.11.002_bib44","doi-asserted-by":"crossref","DOI":"10.1074\/mcp.M111.010132","article-title":"Multisite phosphorylation of human liver cytochrome P450 3A4 enhances its gp78- and CHIP-mediated ubiquitination: a pivotal role of its Ser-478 residue in the gp78-catalyzed reaction","volume":"11","author":"Wang","year":"2012","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.apsb.2019.11.002_bib45","doi-asserted-by":"crossref","first-page":"9443","DOI":"10.1074\/jbc.M110.176685","article-title":"Ubiquitin-dependent proteasomal degradation of human liver cytochrome P450 2E1: identification of sites targeted for phosphorylation and ubiquitination","volume":"286","author":"Wang","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2019.11.002_bib46","doi-asserted-by":"crossref","first-page":"3308","DOI":"10.1074\/jbc.M114.611525","article-title":"Human liver cytochrome P450 3A4 ubiquitination: molecular recognition by UBC7-gp78 autocrine motility factor receptor and UbcH5a-CHIP-Hsc70-Hsp40 E2-E3 ubiquitin ligase complexes","volume":"290","author":"Wang","year":"2015","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2019.11.002_bib47","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.abb.2008.12.001","article-title":"CYP3A4 ubiquitination by gp78 (the tumor autocrine motility factor receptor, AMFR) and CHIP E3 ligases","volume":"483","author":"Pabarcus","year":"2009","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.apsb.2019.11.002_bib48","doi-asserted-by":"crossref","first-page":"4114","DOI":"10.1091\/mbc.12.12.4114","article-title":"HRD4\/NPL4 is required for the proteasomal processing of ubiquitinated ER proteins","volume":"12","author":"Bays","year":"2001","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.apsb.2019.11.002_bib49","doi-asserted-by":"crossref","first-page":"3980","DOI":"10.1074\/jbc.M309938200","article-title":"Distinct steps in dislocation of luminal endoplasmic reticulum-associated degradation substrates: roles of endoplasmic reticulum-bound p97\/Cdc48p and proteasome","volume":"279","author":"Elkabetz","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2019.11.002_bib50","doi-asserted-by":"crossref","first-page":"45676","DOI":"10.1074\/jbc.M409034200","article-title":"AAA ATPase p97\/valosin-containing protein interacts with gp78, a ubiquitin ligase for endoplasmic reticulum-associated degradation","volume":"279","author":"Zhong","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2019.11.002_bib51","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.cell.2004.11.013","article-title":"A series of ubiquitin binding factors connects CDC48\/p97 to substrate multiubiquitylation and proteasomal targeting","volume":"120","author":"Richly","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.apsb.2019.11.002_bib52","doi-asserted-by":"crossref","first-page":"14132","DOI":"10.1073\/pnas.0505006102","article-title":"Inaugural article: recruitment of the p97 ATPase and ubiquitin ligases to the site of retrotranslocation at the endoplasmic reticulum membrane","volume":"102","author":"Ye","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.apsb.2019.11.002_bib53","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1124\/mol.105.021816","article-title":"Endoplasmic reticulum-associated degradation of cytochrome P450 CYP3A4 in Saccharomyces cerevisiae: further characterization of cellular participants and structural determinants","volume":"69","author":"Liao","year":"2006","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.apsb.2019.11.002_bib54","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.1074\/jbc.M110.186981","article-title":"Liver cytochrome P450 3A endoplasmic reticulum-associated degradation: a major role for the p97 AAA ATPase in cytochrome P450 3A extraction into the cytosol","volume":"286","author":"Acharya","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2019.11.002_bib55","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0167-5699(97)84666-X","article-title":"Regulating protein degradation by ubiquitination","volume":"18","author":"Weissman","year":"1997","journal-title":"Immunol Today"},{"key":"10.1016\/j.apsb.2019.11.002_bib56","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/35056563","article-title":"Themes and variations on ubiquitylation","volume":"2","author":"Weissman","year":"2001","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.apsb.2019.11.002_bib57","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.cbpa.2004.09.009","article-title":"Polyubiquitin chains: polymeric protein signals","volume":"8","author":"Pickart","year":"2004","journal-title":"Curr Opin Chem Biol"},{"key":"10.1016\/j.apsb.2019.11.002_bib58","first-page":"1546","article-title":"A field guide to ubiquitylation","volume":"61","author":"Fang","year":"2004","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.apsb.2019.11.002_bib59","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.bbamcr.2004.09.019","article-title":"Ubiquitin: structures, functions, mechanisms","volume":"1695","author":"Pickart","year":"2004","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.apsb.2019.11.002_bib60","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1042\/BST0370937","article-title":"The emerging complexity of protein ubiquitination","volume":"37","author":"Komander","year":"2009","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.apsb.2019.11.002_bib61","doi-asserted-by":"crossref","first-page":"20567","DOI":"10.1073\/pnas.0810611105","article-title":"Ubiquitin signals autophagic degradation of cytosolic proteins and peroxisomes","volume":"105","author":"Kim","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.apsb.2019.11.002_bib62","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.molcel.2009.04.026","article-title":"A role for ubiquitin in selective autophagy","volume":"34","author":"Kirkin","year":"2009","journal-title":"Mol Cell"},{"key":"10.1016\/j.apsb.2019.11.002_bib63","doi-asserted-by":"crossref","first-page":"23916","DOI":"10.1074\/jbc.M110.127936","article-title":"Serine residues in the cytosolic tail of the T-cell antigen receptor alpha-chain mediate ubiquitination and endoplasmic reticulum-associated degradation of the unassembled protein","volume":"285","author":"Ishikura","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2019.11.002_bib64","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1083\/jcb.200908036","article-title":"Ube2j2 ubiquitinates hydroxylated amino acids on ER-associated degradation substrates","volume":"187","author":"Wang","year":"2009","journal-title":"J Cell Biol"},{"key":"10.1016\/j.apsb.2019.11.002_bib65","doi-asserted-by":"crossref","first-page":"15458","DOI":"10.1074\/jbc.M809366200","article-title":"Ubiquitylation on canonical and non-canonical sites targets the transcription factor neurogenin for ubiquitin-mediated proteolysis","volume":"284","author":"Vosper","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2019.11.002_bib66","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nature05542","article-title":"A ubiquitin ligase transfers preformed polyubiquitin chains from a conjugating enzyme to a substrate","volume":"446","author":"Li","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2019.11.002_bib67","doi-asserted-by":"crossref","first-page":"3722","DOI":"10.1073\/pnas.0808564106","article-title":"Mechanistic insights into active site-associated polyubiquitination by the ubiquitin-conjugating enzyme Ube2g2","volume":"106","author":"Li","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.apsb.2019.11.002_bib68","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/nrm3394","article-title":"Atypical ubiquitylation\u2014the unexplored world of polyubiquitin beyond Lys48 and Lys63 linkages","volume":"13","author":"Kulathu","year":"2012","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.apsb.2019.11.002_bib69","doi-asserted-by":"crossref","first-page":"16333","DOI":"10.1021\/bi0515570","article-title":"Regulation of cytochrome P450 2E1 by heat shock protein 90-dependent stabilization and CHIP-dependent proteasomal degradation","volume":"44","author":"Morishima","year":"2005","journal-title":"Biochemistry"},{"key":"10.1016\/j.apsb.2019.11.002_bib70","doi-asserted-by":"crossref","first-page":"35866","DOI":"10.1074\/jbc.M110.167189","article-title":"Liver cytochrome P450 3A ubiquitination in\u00a0vivo by gp78\/autocrine motility factor receptor and C-terminus of Hsp70-interacting protein (CHIP) E3 ubiquitin ligases: physiological and pharmacological relevance","volume":"285","author":"Kim","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2019.11.002_bib71","doi-asserted-by":"crossref","first-page":"4535","DOI":"10.1128\/MCB.19.6.4535","article-title":"Identification of CHIP, a novel tetratricopeptide repeat-containing protein that interacts with heat shock proteins and negatively regulates chaperone functions","volume":"19","author":"Ballinger","year":"1999","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.apsb.2019.11.002_bib72","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/35050618","article-title":"The co-chaperone CHIP regulates protein triage decisions mediated by heat-shock proteins","volume":"3","author":"Connell","year":"2001","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.apsb.2019.11.002_bib73","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1093\/embo-reports\/kve246","article-title":"CHIP is a chaperone-dependent E3 ligase that ubiquitylates unfolded protein","volume":"2","author":"Murata","year":"2001","journal-title":"EMBO Rep"},{"key":"10.1016\/j.apsb.2019.11.002_bib74","doi-asserted-by":"crossref","first-page":"42938","DOI":"10.1074\/jbc.M101968200","article-title":"CHIP is a U-box-dependent E3 ubiquitin ligase: identification of Hsc70 as a target for ubiquitylation","volume":"276","author":"Jiang","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2019.11.002_bib75","first-page":"1","article-title":"Molecular chaperones and the ubiquitin-proteasome system","volume":"vol. 2","author":"Patterson","year":"2005"},{"key":"10.1016\/j.apsb.2019.11.002_bib76","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1258\/ebm.2009.009250","article-title":"Proposal for a role of the Hsp90\/Hsp70-based chaperone machinery in making triage decisions when proteins undergo oxidative and toxic damage","volume":"235","author":"Pratt","year":"2010","journal-title":"Exp Biol Med"},{"key":"10.1016\/j.apsb.2019.11.002_bib77","first-page":"163","article-title":"Tumor cell autocrine motility factor receptor","volume":"59","author":"Nabi","year":"1991","journal-title":"EXS"},{"key":"10.1016\/j.apsb.2019.11.002_bib78","doi-asserted-by":"crossref","first-page":"14422","DOI":"10.1073\/pnas.251401598","article-title":"The tumor autocrine motility factor receptor, gp78, is a ubiquitin protein ligase implicated in degradation from the endoplasmic reticulum","volume":"98","author":"Fang","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.apsb.2019.11.002_bib79","doi-asserted-by":"crossref","first-page":"414","DOI":"10.2174\/138920312802430590","article-title":"gp78: a multifaceted ubiquitin ligase that integrates a unique protein degradation pathway from the endoplasmic reticulum","volume":"13","author":"Chen","year":"2012","journal-title":"Curr Protein Pept Sci"},{"key":"10.1016\/j.apsb.2019.11.002_bib80","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3389\/fncel.2017.00259","article-title":"Gp78 E3 ubiquitin ligase: essential functions and contributions in proteostasis","volume":"11","author":"Joshi","year":"2017","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.apsb.2019.11.002_bib81","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1073\/pnas.0506618103","article-title":"The activity of a human endoplasmic reticulum-associated degradation E3, gp78, requires its Cue domain, RING finger, and an E2-binding site","volume":"103","author":"Chen","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.apsb.2019.11.002_bib82","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1093\/emboj\/19.10.2181","article-title":"A complex of mammalian ufd1 and npl4 links the AAA-ATPase, p97, to ubiquitin and nuclear transport pathways","volume":"19","author":"Meyer","year":"2000","journal-title":"Embo J"},{"key":"10.1016\/j.apsb.2019.11.002_bib83","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/35087056","article-title":"Valosin-containing protein is a multi-ubiquitin chain-targeting factor required in ubiquitin-proteasome degradation","volume":"3","author":"Dai","year":"2001","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.apsb.2019.11.002_bib84","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/414652a","article-title":"The AAA ATPase Cdc48\/p97 and its partners transport proteins from the ER into the cytosol","volume":"414","author":"Ye","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2019.11.002_bib85","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/ncb746","article-title":"Protein dislocation from the ER requires polyubiquitination and the AAA-ATPase Cdc48","volume":"4","author":"Jarosch","year":"2002","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.apsb.2019.11.002_bib86","doi-asserted-by":"crossref","first-page":"R366","DOI":"10.1016\/S0960-9822(02)00862-X","article-title":"Cdc48-Ufd1-Npl4: stuck in the middle with Ub","volume":"12","author":"Bays","year":"2002","journal-title":"Curr Biol"},{"key":"10.1016\/j.apsb.2019.11.002_bib87","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/nrm780","article-title":"Retro-translocation of proteins from the endoplasmic reticulum into the cytosol","volume":"3","author":"Tsai","year":"2002","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.apsb.2019.11.002_bib88","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1128\/MCB.22.2.626-634.2002","article-title":"AAA-ATPase p97\/Cdc48p, a cytosolic chaperone required for endoplasmic reticulum-associated protein degradation","volume":"22","author":"Rabinovich","year":"2002","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.apsb.2019.11.002_bib89","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1083\/jcb.200302169","article-title":"Function of the p97-Ufd1-Npl4 complex in retrotranslocation from the ER to the cytosol: dual recognition of nonubiquitinated polypeptide segments and polyubiquitin chains","volume":"162","author":"Ye","year":"2003","journal-title":"J Cell Biol"},{"key":"10.1016\/j.apsb.2019.11.002_bib90","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/nature02656","article-title":"A membrane protein complex mediates retro-translocation from the ER lumen into the cytosol","volume":"429","author":"Ye","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2019.11.002_bib91","first-page":"95","article-title":"The role of p97\/Cdc48p in endoplasmic reticulum-associated degradation: from the immune system to yeast","volume":"300","author":"Bar-Nun","year":"2005","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.apsb.2019.11.002_bib92","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1038\/ncb0805-742","article-title":"Delivery of ubiquitinated substrates to protein-unfolding machines","volume":"7","author":"Elsasser","year":"2005","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.apsb.2019.11.002_bib93","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.tibs.2006.11.005","article-title":"Cdc48 (p97): a \u201cmolecular gearbox\u201d in the ubiquitin pathway?.","volume":"32","author":"Jentsch","year":"2007","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.apsb.2019.11.002_bib94","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.1091\/mbc.e08-09-0953","article-title":"Dislocation of HMG-CoA reductase and Insig-1, two polytopic endoplasmic reticulum proteins, en route to proteasomal degradation","volume":"20","author":"Leichner","year":"2009","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.apsb.2019.11.002_bib95","doi-asserted-by":"crossref","first-page":"7166","DOI":"10.1074\/jbc.M705893200","article-title":"A proteasomal ATPase contributes to dislocation of endoplasmic reticulum-associated degradation (ERAD) substrates","volume":"283","author":"Lipson","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2019.11.002_bib96","doi-asserted-by":"crossref","first-page":"34889","DOI":"10.1074\/jbc.M109.044875","article-title":"Regulated endoplasmic reticulum-associated degradation of a polytopic protein: p97 recruits proteasomes to Insig-1 before extraction from membranes","volume":"284","author":"Ikeda","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2019.11.002_bib97","doi-asserted-by":"crossref","first-page":"19053","DOI":"10.1074\/jbc.M114.576652","article-title":"Sequential actions of the AAA-ATPase valosin-containing protein (VCP)\/p97 and the proteasome 19 S regulatory particle in sterol-accelerated, endoplasmic reticulum (ER)-associated degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase","volume":"289","author":"Morris","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2019.11.002_bib98","doi-asserted-by":"crossref","first-page":"4283","DOI":"10.1242\/jcs.00817","article-title":"p97, a protein coping with multiple identities","volume":"116","author":"Woodman","year":"2003","journal-title":"J Cell Sci"},{"key":"10.1016\/j.apsb.2019.11.002_bib99","doi-asserted-by":"crossref","first-page":"4606","DOI":"10.1091\/mbc.e06-05-0432","article-title":"Valosin-containing protein (p97) is a regulator of endoplasmic reticulum stress and of the degradation of N-end rule and ubiquitin-fusion degradation pathway substrates in mammalian cells","volume":"17","author":"Wojcik","year":"2006","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.apsb.2019.11.002_bib100","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1042\/BST0320715","article-title":"p97 and close encounters of every kind: a brief review","volume":"32","author":"Dreveny","year":"2004","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.apsb.2019.11.002_bib101","doi-asserted-by":"crossref","first-page":"4834","DOI":"10.1073\/pnas.1015312108","article-title":"Reversible inhibitor of p97, DBeQ, impairs both ubiquitin-dependent and autophagic protein clearance pathways","volume":"108","author":"Chou","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.apsb.2019.11.002_bib102","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1083\/jcb.201002075","article-title":"Cdc48\/p97 and Shp1\/p47 regulate autophagosome biogenesis in concert with ubiquitin-like Atg8","volume":"190","author":"Krick","year":"2010","journal-title":"J Cell Biol"},{"key":"10.1016\/j.apsb.2019.11.002_bib103","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.jsb.2003.10.007","article-title":"The crystal structure of murine p97\/VCP at 3.6A","volume":"144","author":"Huyton","year":"2003","journal-title":"J Struct Biol"},{"key":"10.1016\/j.apsb.2019.11.002_bib104","doi-asserted-by":"crossref","first-page":"21361","DOI":"10.1074\/jbc.M610069200","article-title":"Detailed structural insights into the p97-Npl4-Ufd1 interface","volume":"282","author":"Isaacson","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2019.11.002_bib105","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.str.2008.02.010","article-title":"Improved structures of full-length p97, an AAA ATPase: implications for mechanisms of nucleotide-dependent conformational change","volume":"16","author":"Davies","year":"2008","journal-title":"Structure"},{"key":"10.1016\/j.apsb.2019.11.002_bib106","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1006\/jmbi.1993.1646","article-title":"Structural features of the 26 S proteasome complex","volume":"234","author":"Peters","year":"1993","journal-title":"J Mol Biol"},{"key":"10.1016\/j.apsb.2019.11.002_bib107","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1006\/jsbi.1998.3958","article-title":"26S proteasome structure revealed by three-dimensional electron microscopy","volume":"121","author":"Walz","year":"1998","journal-title":"J Struct Biol"},{"key":"10.1016\/j.apsb.2019.11.002_bib108","doi-asserted-by":"crossref","first-page":"6065","DOI":"10.1016\/S0021-9258(18)53218-X","article-title":"The multicatalytic and 26 S proteases","volume":"268","author":"Rechsteiner","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2019.11.002_bib109","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/978-1-4419-8861-4_5","article-title":"Ubiquitin-mediated proteolysis: an ideal pathway for systems biology analysis","volume":"547","author":"Rechsteiner","year":"2004","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.apsb.2019.11.002_bib110","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nrm1336","article-title":"Proteasomes and their kin: proteases in the machine age","volume":"5","author":"Pickart","year":"2004","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.apsb.2019.11.002_bib111","first-page":"220","article-title":"The 26S proteasome","volume":"vol. 1","author":"Rechsteiner","year":"2005"},{"key":"10.1016\/j.apsb.2019.11.002_bib112","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.tcb.2004.11.003","article-title":"Mobilizing the proteolytic machine: cell biological roles of proteasome activators and inhibitors","volume":"15","author":"Rechsteiner","year":"2005","journal-title":"Trends Cell Biol"},{"key":"10.1016\/j.apsb.2019.11.002_bib113","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.tcb.2010.03.007","article-title":"Assembly, structure, and function of the 26S proteasome","volume":"20","author":"Bedford","year":"2010","journal-title":"Trends Cell Biol"},{"key":"10.1016\/j.apsb.2019.11.002_bib114","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1038\/nature08065","article-title":"Hexameric assembly of the proteasomal ATPases is templated through their C termini","volume":"459","author":"Park","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2019.11.002_bib115","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.molcel.2010.02.035","article-title":"Heterohexameric ring arrangement of the eukaryotic proteasomal ATPases: implications for proteasome structure and assembly","volume":"38","author":"Tomko","year":"2010","journal-title":"Mol Cell"},{"key":"10.1016\/j.apsb.2019.11.002_bib116","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/nature09444","article-title":"The proteasome antechamber maintains substrates in an unfolded state","volume":"467","author":"Ruschak","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2019.11.002_bib117","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0092-8674(94)90462-6","article-title":"Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules","volume":"78","author":"Rock","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.apsb.2019.11.002_bib118","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1126\/science.7732382","article-title":"Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin","volume":"268","author":"Fenteany","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.apsb.2019.11.002_bib119","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1074\/jbc.272.1.182","article-title":"Mechanistic studies on the inactivation of the proteasome by lactacystin in cultured cells","volume":"272","author":"Dick","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2019.11.002_bib120","doi-asserted-by":"crossref","first-page":"10403","DOI":"10.1073\/pnas.96.18.10403","article-title":"Epoxomicin, a potent and selective proteasome inhibitor, exhibits in\u00a0vivo antiinflammatory activity","volume":"96","author":"Meng","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.apsb.2019.11.002_bib121","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1080\/17425255.2019.1621839","article-title":"Pharmacodynamics and pharmacokinetics of proteasome inhibitors for the treatment of multiple myeloma","volume":"15","author":"Baljevic","year":"2019","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.apsb.2019.11.002_bib122","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.mam.2016.05.001","article-title":"Degradation of oxidized proteins by the proteasome: distinguishing between the 20S, 26S, and immunoproteasome proteolytic pathways","volume":"50","author":"Raynes","year":"2016","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.apsb.2019.11.002_bib123","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1074\/jbc.M206279200","article-title":"Ubiquitin conjugation is not required for the degradation of oxidized proteins by proteasome","volume":"278","author":"Shringarpure","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2019.11.002_bib124","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.abb.2012.04.018","article-title":"Differential roles of proteasome and immunoproteasome regulators Pa28alphabeta, Pa28gamma and Pa200 in the degradation of oxidized proteins","volume":"523","author":"Pickering","year":"2012","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.apsb.2019.11.002_bib125","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/363552a0","article-title":"A role for the ubiquitin-dependent proteolytic pathway in MHC class I-restricted antigen presentation","volume":"363","author":"Michalek","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2019.11.002_bib126","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/jlb.57.4.543","article-title":"Pathways for the processing and presentation of antigens to T cells","volume":"57","author":"Monaco","year":"1995","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.apsb.2019.11.002_bib127","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/35056572","article-title":"Antigen processing by the proteasome","volume":"2","author":"Kloetzel","year":"2001","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.apsb.2019.11.002_bib128","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/ni1090","article-title":"Generation of major histocompatibility complex class I antigens: functional interplay between proteasomes and TPPII","volume":"5","author":"Kloetzel","year":"2004","journal-title":"Nat Immunol"},{"key":"10.1016\/j.apsb.2019.11.002_bib129","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1146\/annurev.ge.29.120195.003501","article-title":"The genetics of proteasomes and antigen processing","volume":"29","author":"Monaco","year":"1995","journal-title":"Annu Rev Genet"},{"key":"10.1016\/j.apsb.2019.11.002_bib130","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.coi.2003.11.004","article-title":"Proteasome and peptidase function in MHC-class-I-mediated antigen presentation","volume":"16","author":"Kloetzel","year":"2004","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.apsb.2019.11.002_bib131","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.bbamcr.2004.10.004","article-title":"The proteasome and MHC class I antigen processing","volume":"1695","author":"Kloetzel","year":"2004","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.apsb.2019.11.002_bib132","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/541984","article-title":"New insights into the function of the immunoproteasome in immune and nonimmune cells","author":"Kimura","year":"2015","journal-title":"J Immunol Res"},{"key":"10.1016\/j.apsb.2019.11.002_bib133","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1093\/emboj\/21.11.2636","article-title":"Properties of the hybrid form of the 26S proteasome containing both 19S and PA28 complexes","volume":"21","author":"Cascio","year":"2002","journal-title":"EMBO J"},{"key":"10.1016\/j.apsb.2019.11.002_bib134","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1006\/jmbi.2001.5063","article-title":"Reconstitution of hybrid proteasomes from purified PA700-20 S complexes and PA28alphabeta activator: ultrastructure and peptidase activities","volume":"313","author":"Kopp","year":"2001","journal-title":"J Mol Biol"},{"key":"10.1016\/j.apsb.2019.11.002_bib135","doi-asserted-by":"crossref","first-page":"ra88","DOI":"10.1126\/scisignal.2001232","article-title":"Regulation of the 26S proteasome complex during oxidative stress","volume":"3","author":"Wang","year":"2010","journal-title":"Sci Signal"},{"key":"10.1016\/j.apsb.2019.11.002_bib136","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.freeradbiomed.2011.06.015","article-title":"HSP70 mediates dissociation and reassociation of the 26S proteasome during adaptation to oxidative stress","volume":"51","author":"Grune","year":"2011","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.apsb.2019.11.002_bib137","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1042\/bj3350637","article-title":"Comparative resistance of the 20S and 26S proteasome to oxidative stress","volume":"335","author":"Reinheckel","year":"1998","journal-title":"Biochem J"},{"key":"10.1016\/j.apsb.2019.11.002_bib138","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1006\/abbi.2000.1717","article-title":"Differential impairment of 20S and 26S proteasome activities in human hematopoietic K562 cells during oxidative stress","volume":"377","author":"Reinheckel","year":"2000","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.apsb.2019.11.002_bib139","doi-asserted-by":"crossref","first-page":"29423","DOI":"10.1038\/srep29423","article-title":"CHIP\u2013\/\u2013-mouse liver: adiponectin-AMPK-FOXO-activation overrides CYP2E1-elicited JNK1-activation, delaying onset of NASH: therapeutic implications","volume":"6","author":"Kim","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.apsb.2019.11.002_bib140","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1124\/mol.119.117069","article-title":"Induction via\u00a0functional protein stabilization of hepatic cytochromes P450 upon\u00a0gp78\/autocrine motility factor receptor (AMFR) ubiquitin E3-ligase genetic ablation in mice: therapeutic and toxicological relevance","volume":"96","author":"Kwon","year":"2019","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.apsb.2019.11.002_bib141","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1083\/jcb.104.5.1207","article-title":"Cytochrome P-450 and NADPH-cytochrome P-450 reductase are degraded in the autolysosomes in rat liver","volume":"104","author":"Masaki","year":"1987","journal-title":"J Cell Biol"},{"key":"10.1016\/j.apsb.2019.11.002_bib142","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1432-1033.1991.tb16026.x","article-title":"Acetone-regulated synthesis and degradation of cytochrome P450E1 and cytochrome P4502B1 in rat liver [corrected]","volume":"198","author":"Ronis","year":"1991","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.apsb.2019.11.002_bib143","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/S0026-895X(24)12211-0","article-title":"Native CYP2C11: heterologous expression in Saccharomyces cerevisiae reveals a role for vacuolar proteases rather than the proteasome system in the degradation of this endoplasmic reticulum protein","volume":"61","author":"Murray","year":"2002","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.apsb.2019.11.002_bib144","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1124\/mol.104.009654","article-title":"Vacuolar degradation of rat liver CYP2B1 in Saccharomyces cerevisiae: further validation of the yeast model and structural implications for the degradation of mammalian endoplasmic reticulum P450 proteins","volume":"67","author":"Liao","year":"2005","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.apsb.2019.11.002_bib145","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1146\/annurev-biochem-061516-044908","article-title":"Proteasomal and autophagic degradation systems","volume":"86","author":"Dikic","year":"2017","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.apsb.2019.11.002_bib146","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1083\/jcb.200412022","article-title":"Impairment of starvation-induced and constitutive autophagy in Atg7-deficient mice","volume":"169","author":"Komatsu","year":"2005","journal-title":"J Cell Biol"},{"key":"10.1016\/j.apsb.2019.11.002_bib147","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/nature06639","article-title":"Autophagy fights disease through cellular self-digestion","volume":"451","author":"Mizushima","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2019.11.002_bib148","doi-asserted-by":"crossref","first-page":"438","DOI":"10.4161\/auto.6.4.12244","article-title":"A comprehensive glossary of autophagy-related molecules and processes","volume":"6","author":"Klionsky","year":"2010","journal-title":"Autophagy"},{"key":"10.1016\/j.apsb.2019.11.002_bib149","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1126\/science.1208607","article-title":"Cell biology. Autophagy's top chef","volume":"332","author":"Cuervo","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.apsb.2019.11.002_bib150","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1146\/annurev-biochem-060815-014556","article-title":"Mammalian autophagy: how does it work?.","volume":"85","author":"Bento","year":"2016","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.apsb.2019.11.002_bib151","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1042\/EBC20170035","article-title":"Regulation of selective autophagy: the p62\/SQSTM1 paradigm","volume":"61","author":"Lamark","year":"2017","journal-title":"Essays Biochem"},{"key":"10.1016\/j.apsb.2019.11.002_bib152","doi-asserted-by":"crossref","first-page":"34568","DOI":"10.1074\/jbc.M303221200","article-title":"Interaction codes within the family of mammalian Phox and Bem1p domain-containing proteins","volume":"278","author":"Lamark","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2019.11.002_bib153","doi-asserted-by":"crossref","first-page":"8055","DOI":"10.1128\/MCB.24.18.8055-8068.2004","article-title":"Sequestosome 1\/p62 is a polyubiquitin chain binding protein involved in ubiquitin proteasome degradation","volume":"24","author":"Seibenhener","year":"2004","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.apsb.2019.11.002_bib154","doi-asserted-by":"crossref","first-page":"24131","DOI":"10.1074\/jbc.M702824200","article-title":"p62\/SQSTM1 binds directly to Atg8\/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy","volume":"282","author":"Pankiv","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2019.11.002_bib155","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.cell.2007.10.035","article-title":"Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice","volume":"131","author":"Komatsu","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.apsb.2019.11.002_bib156","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.4161\/cc.8.13.8892","article-title":"NBR1 and p62 as cargo receptors for selective autophagy of ubiquitinated targets","volume":"8","author":"Lamark","year":"2009","journal-title":"Cell Cycle"},{"key":"10.1016\/j.apsb.2019.11.002_bib157","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.molcel.2013.06.020","article-title":"K63 polyubiquitination and activation of mTOR by the p62-TRAF6 complex in nutrient-activated cells","volume":"51","author":"Linares","year":"2013","journal-title":"Mol Cell"},{"key":"10.1016\/j.apsb.2019.11.002_bib158","doi-asserted-by":"crossref","first-page":"3237","DOI":"10.1242\/jcs.126128","article-title":"The LIR motif\u2014crucial for selective autophagy","volume":"126","author":"Birgisdottir","year":"2013","journal-title":"J Cell Sci"},{"key":"10.1016\/j.apsb.2019.11.002_bib159","first-page":"449","article-title":"A selective pathway for degradation of cytosolic proteins by lysosomes","volume":"1","author":"Dice","year":"1990","journal-title":"Semin Cell Biol"},{"key":"10.1016\/j.apsb.2019.11.002_bib160","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1126\/science.273.5274.501","article-title":"A receptor for the selective uptake and degradation of proteins by lysosomes","volume":"273","author":"Cuervo","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.apsb.2019.11.002_bib161","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.cub.2009.11.022","article-title":"Chaperone-assisted selective autophagy is essential for muscle maintenance","volume":"20","author":"Arndt","year":"2010","journal-title":"Curr Biol"},{"key":"10.1016\/j.apsb.2019.11.002_bib162","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/embor.2010.203","article-title":"BAG3 mediates chaperone-based aggresome-targeting and selective autophagy of misfolded proteins","volume":"12","author":"Gamerdinger","year":"2011","journal-title":"EMBO Rep"},{"key":"10.1016\/j.apsb.2019.11.002_bib163","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1091\/mbc.e04-09-0779","article-title":"Characterization of an ERAD gene as VPS30\/ATG6 reveals two alternative and functionally distinct protein quality control pathways: one for soluble Z variant of human alpha-1 proteinase inhibitor (A1PiZ) and another for aggregates of A1PiZ","volume":"17","author":"Kruse","year":"2006","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.apsb.2019.11.002_bib164","doi-asserted-by":"crossref","first-page":"18663","DOI":"10.1074\/jbc.M116.739821","article-title":"Sequestosome 1\/p62 protein is associated with autophagic removal of excess hepatic endoplasmic reticulum in mice","volume":"291","author":"Yang","year":"2016","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2019.11.002_bib165","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/ncb2979","article-title":"Cargo recognition and trafficking in selective autophagy","volume":"16","author":"Stolz","year":"2014","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.apsb.2019.11.002_bib166","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/nature14498","article-title":"Regulation of endoplasmic reticulum turnover by selective autophagy","volume":"522","author":"Khaminets","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2019.11.002_bib167","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.tcb.2015.08.010","article-title":"Ubiquitin-dependent and independent signals in selective autophagy","volume":"26","author":"Khaminets","year":"2016","journal-title":"Trends Cell Biol"},{"key":"10.1016\/j.apsb.2019.11.002_bib168","first-page":"1165","article-title":"Pharmacokinetic consequences of induction of CYP2E1 by ligand stabilization","volume":"25","author":"Chien","year":"1997","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.apsb.2019.11.002_bib169","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2174\/138920006776359293","article-title":"A critical evaluation of the experimental design of studies of mechanism based enzyme inhibition, with implications for in vitro\u2013in vivo extrapolation","volume":"7","author":"Ghanbari","year":"2006","journal-title":"Curr Drug Metab"},{"key":"10.1016\/j.apsb.2019.11.002_bib170","doi-asserted-by":"crossref","first-page":"407","DOI":"10.2174\/138920007780866807","article-title":"Mechanism-based inactivation of cytochrome P450 enzymes: chemical mechanisms, structure\u2013activity relationships and relationship to clinical drug\u2013drug interactions and idiosyncratic adverse drug reactions","volume":"8","author":"Kalgutkar","year":"2007","journal-title":"Curr Drug Metab"},{"key":"10.1016\/j.apsb.2019.11.002_bib171","doi-asserted-by":"crossref","first-page":"384","DOI":"10.2174\/138920008784746382","article-title":"Cytochrome P450 turnover: regulation of synthesis and degradation, methods for determining rates, and implications for the prediction of drug interactions","volume":"9","author":"Yang","year":"2008","journal-title":"Curr Drug Metab"},{"key":"10.1016\/j.apsb.2019.11.002_bib172","doi-asserted-by":"crossref","first-page":"251","DOI":"10.2165\/00002018-199818040-00002","article-title":"Drug interactions with grapefruit juice. Extent, probable mechanism and clinical relevance","volume":"18","author":"Fuhr","year":"1998","journal-title":"Drug Saf"},{"key":"10.1016\/j.apsb.2019.11.002_bib173","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1503\/cmaj.120951","article-title":"Grapefruit-medication interactions: forbidden fruit or avoidable consequences?.","volume":"185","author":"Bailey","year":"2013","journal-title":"Can Med Assoc J"},{"key":"10.1016\/j.apsb.2019.11.002_bib174","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1124\/mol.104.006056","article-title":"Proteasomal degradation of human CYP1B1: effect of the Asn453Ser polymorphism on the post-translational regulation of CYP1B1 expression","volume":"67","author":"Bandiera","year":"2005","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.apsb.2019.11.002_bib175","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1073\/pnas.84.2.551","article-title":"Human anti-endoplasmic reticulum autoantibodies appearing in a drug-induced hepatitis are directed against a human liver cytochrome P-450 that hydroxylates the drug","volume":"84","author":"Beaune","year":"1987","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.apsb.2019.11.002_bib176","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S1054-3589(08)60175-1","article-title":"Autoantibodies against cytochromes P450: role in human diseases","volume":"30","author":"Beaune","year":"1994","journal-title":"Adv Pharmacol"},{"key":"10.1016\/j.apsb.2019.11.002_bib177","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1021\/tx980249i","article-title":"New concepts in immunology relevant to idiosyncratic drug reactions: the \u201cdanger hypothesis\u201d and innate immune system","volume":"12","author":"Uetrecht","year":"1999","journal-title":"Chem Res Toxicol"},{"key":"10.1016\/j.apsb.2019.11.002_bib178","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1385\/CRIAI:18:2:215","article-title":"Xenobiotic-metabolizing enzymes as autoantigens in human autoimmune disorders. An update","volume":"18","author":"Boitier","year":"2000","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.apsb.2019.11.002_bib179","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.autrev.2005.01.002","article-title":"Current trends in drug-induced autoimmunity","volume":"4","author":"Uetrecht","year":"2005","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.apsb.2019.11.002_bib180","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S0026-895X(25)08911-4","article-title":"Anti-liver microsomes autoantibodies and dihydralazine-induced hepatitis: specificity of autoantibodies and inductive capacity of the drug","volume":"42","author":"Bourdi","year":"1992","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.apsb.2019.11.002_bib181","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0016-5085(93)90853-5","article-title":"Cytochromes P-450 in human hepatocyte plasma membrane: recognition by several autoantibodies","volume":"104","author":"Loeper","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1016\/j.apsb.2019.11.002_bib182","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1021\/tx960083q","article-title":"Human cytochrome P450 2E1 is a major autoantigen associated with halothane hepatitis","volume":"9","author":"Bourdi","year":"1996","journal-title":"Chem Res Toxicol"},{"key":"10.1016\/j.apsb.2019.11.002_bib183","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0026-895X(25)09316-2","article-title":"Cytochrome P450 2E1 is a cell surface autoantigen in halothane hepatitis","volume":"50","author":"Eliasson","year":"1996","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.apsb.2019.11.002_bib184","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1053\/gast.1996.v111.pm8698201","article-title":"Cytochrome P4502E1 hydroxyethyl radical adducts as the major antigen in autoantibody formation among alcoholics","volume":"111","author":"Clot","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.apsb.2019.11.002_bib185","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0016-5085(95)90025-X","article-title":"Detection of antibodies against proteins modified by hydroxyethyl free radicals in patients with alcoholic cirrhosis","volume":"108","author":"Clot","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1016\/j.apsb.2019.11.002_bib186","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1124\/mol.55.2.223","article-title":"Autoantibodies against cytochromes P-4502E1 and P-4503A in alcoholics","volume":"55","author":"Lytton","year":"1999","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.apsb.2019.11.002_bib187","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0026-895X(25)08704-8","article-title":"Epitope mapping studies with human anti-cytochrome P450 3A antibodies","volume":"49","author":"Leeder","year":"1996","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.apsb.2019.11.002_bib188","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0168-8278(97)82329-X","article-title":"Plasma membrane cytochromes P450 as neoantigens and autoimmune targets in drug-induced hepatitis","volume":"26","author":"Robin","year":"1997","journal-title":"J Hepatol"},{"key":"10.1016\/j.apsb.2019.11.002_bib189","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1172\/JCI118936","article-title":"Antigenic targets in tienilic acid hepatitis. Both cytochrome P450 2C11 and 2C11-tienilic acid adducts are transported to the plasma membrane of rat hepatocytes and recognized by human sera","volume":"98","author":"Robin","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/j.apsb.2019.11.002_bib190","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1046\/j.1365-2249.2002.01754.x","article-title":"Autoantibodies against cytochrome P450s in sera of children treated with immunosuppressive drugs","volume":"127","author":"Lytton","year":"2002","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.apsb.2019.11.002_bib191","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1517\/14622416.6.1.37","article-title":"Cytochrome P450 3A polymorphisms and immunosuppressive drugs","volume":"6","author":"Thervet","year":"2005","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.apsb.2019.11.002_bib192","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1002\/hep.26564","article-title":"Detection of anti-isoniazid and anti-cytochrome P450 antibodies in patients with isoniazid-induced liver failure","volume":"59","author":"Metushi","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.apsb.2019.11.002_bib193","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0022-3565(25)32069-0","article-title":"Isoniazid hepatoxicity: the relationship between covalent binding and metabolism in\u00a0vivo","volume":"213","author":"Timbrell","year":"1980","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.apsb.2019.11.002_bib194","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1172\/JCI113949","article-title":"Major antigen of liver kidney microsomal autoantibodies in idiopathic autoimmune hepatitis is cytochrome P450db1","volume":"83","author":"Manns","year":"1989","journal-title":"J Clin Invest"},{"key":"10.1016\/j.apsb.2019.11.002_bib195","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1046\/j.1365-2249.1997.4131311.x","article-title":"Cytochrome P4502D6: understanding an autoantigen","volume":"108","author":"Choudhuri","year":"1997","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.apsb.2019.11.002_bib196","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1172\/JCI116843","article-title":"Two different cytochrome P450 enzymes are the adrenal antigens in autoimmune polyendocrine syndrome type I and Addison's disease","volume":"92","author":"Winqvist","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1016\/j.apsb.2019.11.002_bib197","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1016\/0140-6736(92)91829-W","article-title":"21-Hydroxylase, a major autoantigen in idiopathic Addison's disease","volume":"339","author":"Winqvist","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.apsb.2019.11.002_bib198","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/0140-6736(92)91894-E","article-title":"Identification by molecular cloning of an autoantigen associated with Addison's disease as steroid 17 alpha-hydroxylase","volume":"339","author":"Krohn","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.apsb.2019.11.002_bib199","doi-asserted-by":"crossref","first-page":"17448","DOI":"10.1021\/bi9808464","article-title":"Identification of the heme-modified peptides from cumene hydroperoxide-inactivated cytochrome P450 3A4","volume":"37","author":"He","year":"1998","journal-title":"Biochemistry"},{"key":"10.1016\/j.apsb.2019.11.002_bib200","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1667\/RR1729.1","article-title":"A mitochondria-targeted triphenylphosphonium-conjugated nitroxide functions as a radioprotector\/mitigator","volume":"172","author":"Jiang","year":"2009","journal-title":"Radiat Res"},{"key":"10.1016\/j.apsb.2019.11.002_bib201","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1038\/onc.2011.342","article-title":"Molecular chaperone complexes with antagonizing activities regulate stability and activity of the tumor suppressor LKB1","volume":"31","author":"Gaude","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.apsb.2019.11.002_bib202","doi-asserted-by":"crossref","first-page":"30107","DOI":"10.1074\/jbc.M705325200","article-title":"The energy sensor AMP-activated protein kinase directly regulates the mammalian FOXO3 transcription factor","volume":"282","author":"Greer","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2019.11.002_bib203","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.tibs.2014.02.003","article-title":"FOXO transcription factors: key regulators of cellular quality control","volume":"39","author":"Webb","year":"2014","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.apsb.2019.11.002_bib204","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/nrm2190","article-title":"Stressing the role of FoxO proteins in lifespan and disease","volume":"8","author":"van der Horst","year":"2007","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.apsb.2019.11.002_bib205","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/jgh.12021","article-title":"Forkhead box class O transcription factors in liver function and disease","volume":"28","author":"Tikhanovich","year":"2013","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.apsb.2019.11.002_bib206","doi-asserted-by":"crossref","first-page":"30817","DOI":"10.1074\/jbc.M402367200","article-title":"Insulin\/Foxo1 pathway regulates expression levels of adiponectin receptors and adiponectin sensitivity","volume":"279","author":"Tsuchida","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2019.11.002_bib207","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1089\/ars.2010.3403","article-title":"Forkhead box O as a sensor, mediator, and regulator of redox signaling","volume":"14","author":"de Keizer","year":"2011","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.apsb.2019.11.002_bib208","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nrm3311","article-title":"AMPK: a nutrient and energy sensor that maintains energy homeostasis","volume":"13","author":"Hardie","year":"2012","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.apsb.2019.11.002_bib209","first-page":"E1107","article-title":"AICA riboside increases AMP-activated protein kinase, fatty acid oxidation, and glucose uptake in rat muscle","volume":"273","author":"Merrill","year":"1997","journal-title":"Am J Physiol"},{"key":"10.1016\/j.apsb.2019.11.002_bib210","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/nm1557","article-title":"Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions","volume":"13","author":"Yamauchi","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.apsb.2019.11.002_bib211","doi-asserted-by":"crossref","first-page":"12017","DOI":"10.1073\/pnas.0705070104","article-title":"AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1alpha","volume":"104","author":"Jager","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.apsb.2019.11.002_bib212","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/nm788","article-title":"Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase","volume":"8","author":"Yamauchi","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.apsb.2019.11.002_bib213","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1038\/nature08991","article-title":"Adiponectin and AdipoR1 regulate PGC-1alpha and mitochondria by Ca2+ and AMPK\/SIRT1","volume":"464","author":"Iwabu","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2019.11.002_bib214","doi-asserted-by":"crossref","first-page":"39107","DOI":"10.1074\/jbc.M112.412569","article-title":"The autophagy-related gene 14 (Atg14) is regulated by forkhead box O transcription factors and circadian rhythms and plays a critical role in hepatic autophagy and lipid metabolism","volume":"287","author":"Xiong","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2019.11.002_bib215","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S0014-5793(03)00062-0","article-title":"A forkhead transcription factor FKHR up-regulates lipoprotein lipase expression in skeletal muscle","volume":"536","author":"Kamei","year":"2003","journal-title":"FEBS Lett"},{"key":"10.1016\/j.apsb.2019.11.002_bib216","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/s41467-019-08585-4","article-title":"Post-translational regulation of lipogenesis via AMPK-dependent phosphorylation of insulin-induced gene","volume":"10","author":"Han","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2019.11.002_bib217","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.tem.2010.08.010","article-title":"JNK regulation of hepatic manifestations of the metabolic syndrome","volume":"21","author":"Czaja","year":"2010","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.apsb.2019.11.002_bib218","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1053\/j.gastro.2012.06.004","article-title":"A liver full of JNK: signaling in regulation of cell function and disease pathogenesis, and clinical approaches","volume":"143","author":"Seki","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.apsb.2019.11.002_bib219","doi-asserted-by":"crossref","first-page":"149","DOI":"10.5009\/gnl.2012.6.2.149","article-title":"NASH is an inflammatory disorder: pathogenic, prognostic and therapeutic implications","volume":"6","author":"Farrell","year":"2012","journal-title":"Gut Liver"},{"key":"10.1016\/j.apsb.2019.11.002_bib220","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s11901-014-0224-8","article-title":"Mechanisms of liver injury in non-alcoholic steatohepatitis","volume":"13","author":"Duwaerts","year":"2012","journal-title":"Curr Hepatol Rep"},{"key":"10.1016\/j.apsb.2019.11.002_bib221","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1177\/1535370215579161","article-title":"Nonalcoholic fatty liver disease: update on pathogenesis, diagnosis, treatment and the role of S-adenosylmethionine","volume":"240","author":"Noureddin","year":"2015","journal-title":"Exp Biol Med"},{"key":"10.1016\/j.apsb.2019.11.002_bib222","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/978-1-60327-194-3_6","article-title":"Nonalcoholic steatohepatitis, animal models, and biomarkers: what is new?.","volume":"593","author":"Ariz","year":"2010","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.apsb.2019.11.002_bib223","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1089\/ars.2010.3749","article-title":"New insights from rodent models of fatty liver disease","volume":"15","author":"Maher","year":"2011","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.apsb.2019.11.002_bib224","doi-asserted-by":"crossref","first-page":"E685","DOI":"10.1152\/ajpendo.00283.2010","article-title":"Fructose: a highly lipogenic nutrient implicated in insulin resistance, hepatic steatosis, and the metabolic syndrome","volume":"299","author":"Dekker","year":"2010","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.apsb.2019.11.002_bib225","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1002\/hep.26594","article-title":"High-fat and high-sucrose (western) diet induces steatohepatitis that is dependent on fructokinase","volume":"58","author":"Ishimoto","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.apsb.2019.11.002_bib226","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1038\/ncomms3434","article-title":"Endogenous fructose production and metabolism in the liver contributes to the development of metabolic syndrome","volume":"4","author":"Lanaspa","year":"2013","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2019.11.002_bib227","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.jhep.2018.01.019","article-title":"Fructose and sugar: a major mediator of non-alcoholic fatty liver disease","volume":"6","author":"Jensen","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.apsb.2019.11.002_bib228","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.cmet.2011.03.009","article-title":"AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice","volume":"13","author":"Li","year":"2011","journal-title":"Cell Metab"},{"key":"10.1016\/j.apsb.2019.11.002_bib229","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.cmet.2012.06.014","article-title":"Ablation of gp78 in liver improves hyperlipidemia and insulin resistance by inhibiting SREBP to decrease lipid biosynthesis","volume":"16","author":"Liu","year":"2012","journal-title":"Cell Metab"},{"key":"10.1016\/j.apsb.2019.11.002_bib230","doi-asserted-by":"crossref","first-page":"23984","DOI":"10.1074\/jbc.M302683200","article-title":"Overexpression of the tumor autocrine motility factor receptor Gp78, a ubiquitin protein ligase, results in increased ubiquitinylation and decreased secretion of apolipoprotein B100 in HepG2 cells","volume":"278","author":"Liang","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2019.11.002_bib231","article-title":"Gp78, an E3 ubiquitin ligase acts as a gatekeeper suppressing nonalcoholic steatohepatitis (NASH) and liver cancer","volume":"10","author":"Zhang","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.apsb.2019.11.002_bib232","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/hep.24690","article-title":"Activation of autophagy protects against acetaminophen-induced hepatotoxicity","volume":"55","author":"Ni","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.apsb.2019.11.002_bib233","doi-asserted-by":"crossref","first-page":"709","DOI":"10.4161\/auto.19659","article-title":"Targeting autophagy for drug-induced hepatotoxicity","volume":"8","author":"Ni","year":"2012","journal-title":"Autophagy"},{"key":"10.1016\/j.apsb.2019.11.002_bib234","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1093\/toxsci\/kfs133","article-title":"Liver-specific loss of Atg5 causes persistent activation of Nrf2 and protects against acetaminophen-induced liver injury","volume":"127","author":"Ni","year":"2012","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.apsb.2019.11.002_bib235","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.redox.2013.10.008","article-title":"Inhibition of autophagy promotes CYP2E1-dependent toxicity in HepG2 cells via elevated oxidative stress, mitochondria dysfunction and activation of p38 and JNK MAPK","volume":"1","author":"Wu","year":"2013","journal-title":"Redox Biol"},{"key":"10.1016\/j.apsb.2019.11.002_bib236","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1083\/jcb.201208152","article-title":"The cell biology of disease: lysosomal storage disorders: the cellular impact of lysosomal dysfunction","volume":"199","author":"Platt","year":"2012","journal-title":"J Cell Biol"},{"key":"10.1016\/j.apsb.2019.11.002_bib237","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1053\/j.gastro.2011.04.038","article-title":"Functions of autophagy in hepatic and pancreatic physiology and disease","volume":"140","author":"Czaja","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.apsb.2019.11.002_bib238","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1042\/BJ20120820","article-title":"Nitric oxide-dependent CYP2B degradation is potentiated by a cytokine-regulated pathway and utilizes the immunoproteasome subunit LMP2","volume":"445","author":"Sun","year":"2012","journal-title":"Biochem J"},{"key":"10.1016\/j.apsb.2019.11.002_bib239","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/hep.26946","article-title":"Reduced adiponectin signaling due to weight gain results in nonalcoholic steatohepatitis through impaired mitochondrial biogenesis","volume":"60","author":"Handa","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.apsb.2019.11.002_bib240","doi-asserted-by":"crossref","first-page":"7352","DOI":"10.3390\/ijms15057352","article-title":"Molecular mechanisms and new treatment strategies for non-alcoholic steatohepatitis (NASH)","volume":"15","author":"Takaki","year":"2014","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2019.11.002_bib241","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1126\/science.aab3896","article-title":"Fructose-driven glycolysis supports anoxia resistance in the naked mole-rat","volume":"356","author":"Park","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.apsb.2019.11.002_bib242","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1007\/s10620-016-4054-0","article-title":"Role of dietary fructose and hepatic de novo lipogenesis in fatty liver disease","volume":"61","author":"Softic","year":"2016","journal-title":"Dig Dis Sci"}],"container-title":["Acta Pharmaceutica Sinica B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383519309451?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383519309451?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T16:43:18Z","timestamp":1761928998000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211383519309451"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":242,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S2211383519309451"],"URL":"https:\/\/doi.org\/10.1016\/j.apsb.2019.11.002","relation":{},"ISSN":["2211-3835"],"issn-type":[{"value":"2211-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cytochrome P450 endoplasmic reticulum-associated degradation (ERAD): therapeutic and pathophysiological implications","name":"articletitle","label":"Article Title"},{"value":"Acta Pharmaceutica Sinica B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apsb.2019.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}